Nkarta (NKTX) Total Current Liabilities (2019 - 2026)

Nkarta's (NKTX) quarterly Total Current Liabilities came in at $18.2 million in Q1 2026, down 2.93% year-on-year from $18.8 million in Q1 2025, and down 18.23% quarter-over-quarter from $22.3 million in Q4 2025.

Nkarta (NKTX) Total Current Liabilities (2019 - 2026) Analysis & Trends

Nkarta's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $18.2 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 2.93% year-over-year to $18.2 million in Q1 2026; TTM through Mar 2026 was $18.2 million, a 2.93% decrease from a year earlier, with the FY2025 full-year figure at $22.3 million, up 17.7% from the prior year.
  • Total Current Liabilities slipped to $18.2 million in Q1 2026 per NKTX's latest filing, from $22.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $26.6 million in Q2 2023 and bottomed at $10.8 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $22.0 million (2022), against an average of $20.9 million.
  • Across the five-year window, Total Current Liabilities soared 139.63% in 2023 and slipped 21.61% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $22.0 million in 2022, then grew by 5.82% to $23.3 million in 2023, then decreased by 18.92% to $18.9 million in 2024, then rose by 17.7% to $22.3 million in 2025, then slipped by 18.23% to $18.2 million in 2026.
  • Per Business Quant, the three latest NKTX Total Current Liabilities figures stand at $18.2 million (Q1 2026), $22.3 million (Q4 2025), and $19.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Nkarta 170.79 Mn 170.79 Mn - 18.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.21 Mn
Dec 31, 2025 22.27 Mn
Sep 30, 2025 18.99 Mn
Jun 30, 2025 18.93 Mn
Mar 31, 2025 18.76 Mn
Dec 31, 2024 18.92 Mn
Sep 30, 2024 22.47 Mn
Jun 30, 2024 20.86 Mn
Mar 31, 2024 22.19 Mn
Dec 31, 2023 23.33 Mn
Sep 30, 2023 25.64 Mn
Jun 30, 2023 26.61 Mn
Mar 31, 2023 25.98 Mn
Dec 31, 2022 22.05 Mn
Sep 30, 2022 26.43 Mn
Jun 30, 2022 13.18 Mn
Mar 31, 2022 10.84 Mn
Dec 31, 2021 12.94 Mn
Sep 30, 2021 12.05 Mn
Jun 30, 2021 10.26 Mn